- Previous Close
0.5143 - Open
0.5068 - Bid 0.5000 x --
- Ask 0.5600 x --
- Day's Range
0.5068 - 0.5068 - 52 Week Range
0.2900 - 0.9800 - Volume
35 - Avg. Volume
17,655 - Market Cap (intraday)
11.94M - Beta (5Y Monthly) 1.86
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4400 - Earnings Date Jun 26, 2025 - Jun 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
www.petvivo.comRecent News: PETV
View MorePerformance Overview: PETV
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PETV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PETV
View MoreValuation Measures
Market Cap
12.84M
Enterprise Value
15.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.87
Price/Book (mrq)
--
Enterprise Value/Revenue
15.88
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-159.92%
Return on Equity (ttm)
-8,616.61%
Revenue (ttm)
956.05k
Net Income Avi to Common (ttm)
-8.63M
Diluted EPS (ttm)
-0.4400
Balance Sheet and Cash Flow
Total Cash (mrq)
28.89k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.42M